ANGLE plc (LON:AGL – Get Free Report)’s share price was up 20.5% during mid-day trading on Thursday . The stock traded as high as GBX 24 ($0.30) and last traded at GBX 23.50 ($0.30). Approximately 3,158,937 shares traded hands during trading, a decline of 1% from the average daily volume of 3,198,614 shares. The stock had previously closed at GBX 19.50 ($0.24).
Wall Street Analysts Forecast Growth
Separately, Berenberg Bank reissued a “buy” rating and issued a GBX 70 ($0.88) price objective on shares of ANGLE in a research report on Wednesday, April 24th.
Check Out Our Latest Analysis on AGL
ANGLE Stock Up 20.5 %
ANGLE Company Profile
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.
See Also
- Five stocks we like better than ANGLE
- Industrial Products Stocks Investing
- Roblox: The Bottom Just Fell Out of the Metaverse
- What is MarketRankā¢? How to Use it
- Airbnb Stock Plummets After Earnings, But is It a Buy?
- What is Put Option Volume?
- Uber’s Earnings Drop Is Investors Opportunity
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.